Skip to main content
PLOS One logoLink to PLOS One
. 2023 Feb 6;18(2):e0281424. doi: 10.1371/journal.pone.0281424

Modelling of thrombus formation using smoothed particle hydrodynamics method

Alessandra Monteleone 1,#, Alessia Viola 1,2,#, Enrico Napoli 2, Gaetano Burriesci 1,3,*
Editor: Alessio Alexiadis4
PMCID: PMC9901800  PMID: 36745608

Abstract

In this paper a novel model, based on the smoothed particle hydrodynamics (SPH) method, is proposed to simulate thrombus formation. This describes the main phases of the coagulative cascade through the balance of four biochemical species and three type of platelets. SPH particles can switch from fluid to solid phase when specific biochemical and physical conditions are satisfied. The interaction between blood and the forming blood clot is easily handled by an innovative monolithic FSI approach. Fluid-solid coupling is modelled by introducing elastic binds between solid particles, without requiring detention and management of the interface between the two media. The proposed model is able to realistically reproduce the thromboembolic process, as confirmed by the comparison of numerical results with experimental data available in the literature.

1. Introduction

Cardiovascular diseases (CVDs) are the main causes of mortality in the world, representing 30% of all global deaths [1]. Hence, there is a pressing need to develop novel tools to diagnose and manage these dysfunctions. Thrombosis is one of the main causes of CVD, that results in the formation of a clot that can obstruct the physiological blood circulation, or fragment and flow through the cardiovascular system to critical organs, thus causing disorders such as ictus, stroke or pulmonary embolism.

Thrombus formation and its pathological role have been investigated for centuries [2]; however, only in the second half of the nineteenth century some fundamental progress was made to provide some systematic understanding of the process. In 1856 Virchow [3] published his observations on the influence of blood flow conditions on platelet activation and, consequently, on thrombus formation. This led to the elaboration of the Virchow’s triad, that identifies changes in blood components (hypercoagulability), vessel wall surface (endothelial injury) or flow characteristics (stasis) as synergic contributors to the phenomenon. Nowadays this theory is still accepted and used to predict the process.

The coagulation process is a sequence of events designed to limit potential blood losses, thus leading to hemostasis. Hemostasis is a complex physiological process due to the interaction between blood, platelets, clotting factors and coagulation inhibitors. The process can be subdivided into primary and secondary hemostasis. In the first phase, adhesion, activation, and aggregation of platelets occur [4]. The result is a biological structure called platelet plug. Platelets, that represent the key parameters leading to thrombosis, can be activated by a long exposure to high shear stress or chemical agonist enzymes like adenosine diphosphate or thromboxane. Another platelet activation mechanism is the interaction with the Von Willebrand factor affecting the adhesion of platelets to the injured tissue walls [5].

The coagulative cascade is the process behind the thrombus formation and represents the heart of secondary hemostasis. The clotting enzymes, called factors, are present in the blood in the inactive form and indicated with the roman numerals XII, XI, IX, VIII, VII, X, V, II, I. They can be switched to the active form (XIIa, XIa, IXa, VIIIa, VIIa, Xa, Va, IIa, Ia) through complex biochemical interactions. In particular, the clotting process can be triggered via intrinsic or extrinsic pathways, both leading to fibrin activation. Specifically, factor XIIa and factor VIIa/Tissue Factor (TF) are triggering variables of the intrinsic and the extrinsic pathways, respectively, and both start the common path of factor Xa/Va. Each of these enzymes activates the formation of the complex prothrombin (II) which catalyses the conversion into thrombin (IIa). The latter acts as an enzyme by transforming fibrinogen (I) into filaments of fibrin (Ia) that trap platelets, blood cells and plasma, causing the formation of a fibrin clot, that gets deposited on the platelet plug mesh (previously activated from primary hemostasis).

Thrombus is a clot that forms inside a vessel when the hemostatic process becomes abnormally activated, and can result in a partial or complete obstruction of the vessel lumen. When the lumen is only partial barred, the altered hemodynamics caused by the narrowing may cause the growth of the clot and, eventually, levels of shear stress and pressure differences sufficient to detach the full clot of parts of it from the anchor point. These masses, released in the bloodstream, can travel to smaller vessels and obstruct the blood supply to the downstream tissues, causing their death.

More commonly, clots associated with primary hemostasis generate in the arterial system around injured atherosclerotic plaques and usually occur at regions of high shear flow. They are characterised by predominance of platelets (hence also referred to as white thrombi), and are common cause of myocardial infarction and stroke. Clots associate with secondary hemostasis may arise without endothelial wall damage and are promoted by areas of slow flow shear rate typically occurring in the venous system. These are characterised by predominance of red cells (hence also called red thrombi), and are a common cause of venous thromboembolism and pulmonary embolism [6].

Given the complexity of the process and the large number of chemical or physical variables involved, numerical modelling represents an attractive tool to simulate the phenomenon of thrombosis. Microscopic and macroscopic thrombus models, analysing the mechanism at different scales, have been proposed in the literature [7]. Zhang et al. [8] and Gao et al. [9] implemented a novel multiscale approach based on discrete particle methods to model thrombus formation in cardiovascular diseases by coupling the macroscopic flow conditions with cellular and molecular effects of platelet mechanical activation. Xu et al. [10] proposed a multi-scale approach where fluid was simulated on the macro-scale using dissipative particle dynamics, and the fine-scale receptors’ biochemical reactions were modelled by coarse-grained molecular dynamics. Most of the macroscopic models are based on Computational Fluid dynamics (CFD) analysis, where convection-diffusion equations are solved to describe the interaction between blood flow and chemical or biological agents involved in thrombosis process [11]. In this framework, Sorensen et al. [12] defined a novel model able to show the mechanism of platelet activation and aggregation in the proximity of to the vessel wall, including the action of chemical agonists species, through a weight function. Moreover, they emphasised the key role of thrombin during thrombus formation. Leiderman and Fogelson [13] presented a novel continuum blood clotting model to reproduce the interactions among the main chemical species, the platelet concentration and flow transport aspects linked to shear rate. Anand et al. [14] described the formation and dissolution of blood clot using biochemical reactions and rheological factors, focusing on the role of fibrin.

CFD simulations have also been used to understand complex pathologies involving thrombus formation. In this context, Sarrami et al. [4] developed a computational model to predict the thrombogenic dynamics in intracranial aneurysms treated with flow-diverter devices. Menichini et al. [15] proposed a novel hemodynamics-based model to predict the formation of thrombus in type B aortic dissection, where shear rate, fluid residence time and platelet distribution were used to evaluate thrombosis and simulate its growth. Vella et al. [16] evaluated thromboembolic risk in left atrial appendage under atrial fibrillation pathology using an ideal geometry and imposing the wall movement under different blood flow conditions.

Although in the literature there are numerous examples of mathematical models or CFD techniques that describe blood clotting or thrombus formation, fluid-structure interaction (FSI) approaches have recently been applied to describe the process more realistically. Generally, FSI is used to model multiphysics phenomena that occur in systems where the fluid flow and deformable structure interact synergically, as in common cardiovascular applications [17]. FSI approaches can be classified into partitioned and monolithic. In partitioned FSI, two different solvers are used to describe the fluid and solid phases, and the mutual interaction occurs at the interface separating the two domains. In particular, fluid flows are commonly described using Eulerian formulations, whilst solid are modelled through Lagrangian approaches. The coupling of the fluid and solid domains is commonly achieved employing Arbitrary-Lagrangian-Eulerian (ALE) techniques [1821] or Immersed Boundary (IB) strategies [22]. On the other hand, in monolithic methods both solid and fluid domains are treated with a unique solver and no interface is required. In this case, Fully Eulerian [23, 24] or Lagrangian [2529] formulations are adopted in the whole domain.

Recently, a number of particle techniques had been developed to describe thrombosis. Tsubota et al. [30] presented a semi-implicit two-dimensional moving particle approach to model thrombus formation after Fontan surgery. In this model, fluid particles are converted into solid phase by adding internal spring forces when blood stasis condition occurs (the model does not consider biochemical factors). Masalceva et al. [31] developed a two-dimensional particle-based model including thrombus shell as aggregate of particles and thrombin specie. Also this approach neglects the biochemical reactions of the coagulation cascade and fibrin formation. Wang et al. [32] proposed a novel particle method to simulate thrombus formation employing a velocity decay factor linked to the fibrin concentration, to take into account the interaction with blood. Wang et al. [33] developed a dissipative particle dynamics model to study the adhesion and aggregation process of injured platelets on the collagen surface, by incorporating a model of high non-physiological shear stresses traumatised platelets to a viscoelastic model.

In the context of the Lagrangian particle method, smoothed particle hydrodynamics (SPH) has recently been adopted for the modelling of thrombosis considering the influence of blood flow, platelets and biochemical factors [34, 35]. Chui et al. [36] used SPH to model the adhesion and the aggregation of clot particles and the mechanism governed by physical triggers (i.e. low shear stress). Al Saad et al. [37] idealised a SPH model to describe thrombus formation, where platelet adhesion and aggregation is obtained through elastic forces that depend exclusively on geometrical distances from an injured vessel. Ariane et al. [38] proposed a two-dimensional model to simulate the interaction between blood flow and emboli-like structures in a double venous valve system. In this approach no particle agglomeration is used to model emboli structures, that are considered as fixed. This technique was extended by Baksamawi et al. [39], including an algorithm based on geometrical distance for particle agglomeration.

This paper presents a new three-dimensional numerical method based on SPH for the simulation of thrombus formation. Contrary to previous works, the proposed approach efficiently combines the biomechanical and biochemical processes in the thrombosis phenomenon. Four biochemical species and three platelets states are considered to replicate the main phases of the coagulative cascade. A particle agglomeration/dissolution algorithm is proposed, able to model both thrombus formation and growth, as well as embolisation. The fluid-solid coupling is enforced through to the inclusion of elastic forces between solid particles, which are established by recruiting fluid particles when specific hydrodynamic and biochemical conditions are satisfied. An innovative monolithic FSI approach is developed to describe the interaction between blood and the forming thrombus using a single solver. The model is implemented in the open-source package PANORMUS (PArallel Numerical Open-souRce Model for Unsteady flow Simulations) [40]. The proposed approach was validated comparing the results with experimental data available in literature [41].

2. SPH formulation

In the SPH method, the domain is described through a finite number N of particles having own mass, density, volume and other physical properties. The field variables at each particle are obtained using discrete convolution integrals with filter functions of assigned shape, named kernel functions W. The kernel function has a characteristic length named smoothing length, indicated as h, which controls the influence domain of W. Each i particle has a support domain, Ωi, which includes all the surrounding particles having distance from the position of i (xi) lower than the product between h and a scalar factor k, whose value depends on the shape of the specific kernel function. In this study, the Wendland function was used [42], where the proportionality constant k between the radius of the support domain and the smoothing length h is equal to 2. The total number of particles N depends on the isotropic starting distance Δx, which is commonly assigned as proportional to the smoothing length h. In this study this distance was assumed equal to Δx = kh/2 as reported by [40, 43, 44]. The hydrodynamic variable a computed at the position xi of the i particle can be expressed as

ai=j=1NimjρjfxjWij (1)

where Ni is the number of j particles lying into Ωi; mj and ρj are the mass and density of j; and Wij = W(xixj, h).

In SPH simulations of incompressible flows, the weakly compressible (WCSPH) and truly incompressible (ISPH) approaches can be used. In the WCSPH scheme, a thermodynamics equation of state is introduced to relate pressure and density. In the ISPH algorithm the pressure field is obtained implicitly by solving a system of Pressure Poisson Equations (PPEs), following the projection method proposed by Chorin [45], thereby satisfying the incompressibility severely. In this study, the ISPH scheme is employed, where a fractional-step procedure is used to solve the momentum and continuity equations. For a detailed description see [46]. In the first step of the procedure, named predictor-step, the momentum equation is solved removing the pressure gradient term, so as to obtain the intermediate velocity u*. In SPH approximation, this equation can be written as

ui*-uirΔt+32Diffir-12Diffir-1-fi=0 (2)

where Δt is the time step, the index r indicates the time instant, ui* is the intermediate velocity of the i particle, uir is the velocity at time r, and fi is the mass force per unit mass acting on the i particle. In Eq 2, Diffi is the diffusive term which is calculated using the Adams–Bashforth scheme [47] to obtain a second-order accurate explicit approximation

Diffi=-j=1Nimjνi+νjxi-xjWijdij2ui-uj (3)

where ∇Wij is the gradient of the kernel function and dij is the distance between the i and j particles.

The PPE are then solved to obtain the corrective velocity

j=1Ni2mjρjxi-xjWijdij2ψi-ψj=1Δtj=1Nimjρjui*-uj*Wij (4)

where ψ is the pseudo-pressure, which has the dimension of the kinematic pressure pϱ.

The updated velocity uir+1 is finally obtained as

uir+1=ui*-Δtj=1Nimjρjψi-ψjWij (5)

The boundary at solid walls is treated adopting a mirror particles procedure, based on the mirroring of the particles in the vicinity of the wall, to impose suitable boundary conditions and overcome the truncation of the kernel function at the walls. A detailed description of the procedure is provided in [40]. The inflow/outflow boundaries are treated following the approach described in [46].

3. The proposed thrombus formation model

3.1 Biochemical species and platelets activation

The coagulative cascade takes a leading role in thrombus formation. As shown in Fig 1, a large number of factors are involved in process. In this study, four biochemical species were considered, to simplify and simulate the clot formation: prothrombin (pt), thrombin (th), fibrinogen (fg) and fibrin (fi).

Fig 1. Schematic view of the coagulative cascade.

Fig 1

These species, highlighted in red in the figure, come into play at the conclusive stage of the coagulative cascade, when the formed fibrin interacts with activated platelets. The proposed model also includes three platelet states: resting platelets (rp), activated platelets (ap) and fibrin bound aggregated platelets (bp).

The transport of the modelled species through the flow domain was evaluated by solving the convection-diffusion equation

ΔCsΔt-αs2Cs-Ss=0 (6)

where C is the time dependent concentration of the generic specie (s = pt, th, fg, fi, rp, ap, bp), αs and Ss are the diffusivity and the source term, respectively, and ΔC⁄Δt is the total derivative operator that, in the Lagrangian formulation, includes the convective term. In SPH, the concentration is associated at each mass point. Therefore, for the generic i particle the value of the concentration for the species s, Ci,s, can be calculated at the updated time step (r+1) as

Ci,sr+1-Ci,sr-αs3Diffir2-Diffir-12Δt+SsΔt=0 (7)

with the diffusive term Diffi

Diffi=-j=1Nimjνi+νjxi-xjWijdij2Ci,s-Cj,s (8)

where Cj,s is the concentration of s associated to the j particle lying in the support domain of i and the other symbols are known.

The source terms for the modelled species are summerised below

Sth=kthrpCrpCpt+kthapCapCpt (9)
Spt=-Sth (10)
Sfi=kfithCthCfgKm,fith+Cfg (11)
Sfg=-Sfi (12)
Sap=kapCrp-kbpϕpbfiCap (13)
Srp=-kapCrp (14)
Sbp=kbpϕpbfiCap (15)

The conversion of prothrombin to thrombin was assumed to occur on the surface of resting and activated platelets having kinetic constants kthrp and kthap, respectively (see Table 1). According to Rosing [48], activated platelets support thrombin generation at a much higher rate than resting platelets, thus different values of kinetic constants were adopted for rp and ap. Thrombin promotes the conversion of fibrinogen to fibrin and the activation of resting platelets. The generation of fibrin promoted by thrombin was assumed to follow Michaelis-Menten kinetics [49] with kinetic constants kfith and Km,fith (see Table 1). For the activation of platelets, a function of local agonist concentrations was employed for the kinetic constant kap, as discussed in [12]. This function evaluates the impact of each single specie on the rate of platelet activation and can be expressed as

kap=0,Ω<1Ωtact,Ω1 (16)

where tact is the platelets activation time equal to 1 s [12]. The activation function Ω can be written as

Ω=s=1NswsCsCs* (17)

where ws is the weight assigned to the agonist s, Cs is the concentration of the agonist s and Cs* is the threshold value for the concentration of s. In the proposed model, thrombin was considered as the only agonist specie, as it typically contributes to most of the platelet activation phenomenon. Hence, Eq 17 reduces to

Ω=wthCthCth* (18)

where wth = 1 and Cth* is the threshold concentration for the thrombin. The latter was set equal to 9.11 ⋅ 10−10 M, as recommended in the literature [12, 50] (see Table 1). Therefore, conversion from resting to activated platelets is achieved when the concentration of the thrombin reaches the threshold value Cth*.

Table 1. Values of reactions kinetic, diffusive coefficients and initial concentrations adopted in the model.

Biochemical reactions kinetic constants
Symbol Value UM References
kthrp 6.50 ⋅ 10−10 U PLT-1 s-1 μM-1 [12]
kthap 3.69 ⋅ 10−10 U PLT-1 s-1 μM-1 [12]
Km,fith 3160 nM [53]
kfith 59 s-1 [53]
k pb 1 ⋅ 104 s-1 [13]
Cth* 9.11 ⋅ 10−10 M [12]
C fi,50 600 nM [4]
Diffusion Coefficients
Dth 6.47 ⋅ 10−7 cm2 s-1 [53]
Dfi 2.47 ⋅ 10−7 cm2 s-1 [53]
Dap 2.50 ⋅ 10−7 cm2 s-1 [13]
Dbp 0 cm2 s-1 [4]
Biochemical Initial Concentrations
Cpt 1400 nM [4]
Cfg 7000 nM [4]
Crp 2 ⋅ 108 PLT ml-1 [4]
Cap 1 ⋅ 107 PLT ml-1 [4]

Activated platelets aggregate to the fibrin network to form bound platelets and, thus, the clot.

Following [4], thrombin-induced fibrin generation and its effect on platelet trapping and aggregation is modelled by means of a second order Hill function ϕpbfi that describes processes involving cooperative binding events [51].

ϕbpfi=Cfi2Cfi2+Cfi,502 (19)

where Cfi,50 is the half-saturation constant (concentration of fibrin where the half-maximal occupation occurs) [51].

The constants and parameters used in the model are obtained from experimental studies available in the literature [4, 12, 48, 5254]. These values, listed in Table 1, are general and applicable in different flow conditions [4, 12].

3.2 Trigger factor and boundary conditions

A trigger factor can be used as the start condition for thrombus formation. Since thrombin is considered to have the greater contribution to the coagulation process (leading to platelet activation, fibrin mesh generation and bound platelets formation), the triggering is imposed as flux boundary conditions for thrombin concentration at the injured wall.

Fig 2 summarises, with a 2D sketch, the boundary conditions imposed for the modelled species at inflow/outflow boundaries and at healthy and injured walls.

Fig 2. Boundary conditions for the species involved in the coagulation cascade process.

Fig 2

Circles: effective particle; squares: mirror particles; red bold line: injured wall.

Specifically, at the healthy vessel walls (including inflow/outflow boundaries), homogeneous Neumann conditions are imposed for the concentration of all the species Csn=0, where n is the direction normal to the boundary (pointing towards the interior of the domain). This is achieved by imposing the concentrations of the mirror particle equal to that of the generating particle. In Fig 2 the concentration of mirror particle B’ (black square), generated through wall boundary, is equal to the concentration of the generating particle B (black circle). The same occurs for inflow and outflow boundaries (mirror particles A’ and E’, respectively). On the other hand, at the injured wall region (red bold line in Fig 2), a non-null value for the normal derivative of thrombin concentration is imposed. To this aim, the concentration of the D’ mirror particle (red square) generated through the injured wall is obtained through a linear extrapolation based on the value of the generating particle D and the assigned concentration of thrombin at the injured wall, indicated as Cw,th

CD',th=2Cw,th-CD,th (20)

3.3 Thrombus formation

In the proposed model, the concentrations of pt, th, fg, fi, rp, ap and bp are evaluated at each particle through the convection-diffusion described by Eq 7, with the source terms in Eqs 915. Moreover, it was assumed that the concentrations of the species do not affect the blood velocity in normal conditions, in the absence of thrombus. On the other hand, a monolithic fluid-structure interaction approach is used when fluid blood particles convert to solid particles, mimicking the presence of thrombus.

The scheme represented in Fig 3 describes the proposed thrombus formation model. Considering the generic i particle, the concentration of thrombin Ci,th is calculated solving the convection-diffusion Eq 7 with source term from Eq 9. Eq 7 has very low kinetic reaction in the bulk, whilst it is accelerated at the injured wall introducing a flux boundary condition for thrombin, as described in section 3.2. Thrombin promotes the conversion of fibrinogen Ci,fg into fibrin Ci,fi through the source term of Eq 11. Thrombin allows the conversion of resting platelets into activated platelets (Eq 7 + source term in Eq 13). Since the function Ω is greater than 1 (Eq 18) and the kinetic constant kpa in Eq 16 is, therefore, greater than 0, the activation of platelets begins when the concentration of thrombin Ci,th exceeds the threshold value Cth*. Activated platelets connected to the fibrin network generate bound platelets (Eq 7 + source term of Eq 15). Therefore, if the concentration of bound platelet Ci,bp exceeds a set limit Cbp*, then the i fluid particle is switched to a solid particle by enforcing spring connections with the neighboring solid particles. On the other hand, if Ci,bp is below Cbp*, i remains a fluid particle.

Fig 3. Schematic representation of the proposed thrombus model.

Fig 3

In Fig 4a, which represents a snapshot at time instant r, all the represented particles have a concentration of bound platelets lower than the threshold value Cbp*. These particles (represented as full black circles) are treated as fluid particle following the ISPH formulation described in section 2. At the r + 1 time step (see Fig 4b), the concentration of Cbp for particles A, B, C and E exceeds the threshold value. These particles, represented in figure as red full circles, are converted into solid particles by introducing internal elastic forces to simulate the solid behavior. A procedure similar to that proposed by Monteleone et al. [55] is adopted here to obtain the elastic forces acting on the solid particles. However, instead of separating the fluid and solid domains through FSI-interfaces, in the proposed model, particles are simply switched from fluid to solid phase by adding spring links. This approach does not require the identification of the interface separating the two media. Specifically, when a fluid particle becomes a solid particle, it is linked to the neighboring solid particles having a distance less than kh from it (particles lying in the dashed circle). In Fig 4b, the particle A is linked to B and C through springs, whilst E is not connected to A, being the distance between the two particles, dAE, greater than kh.

Fig 4. Sketch of the solid particle formation.

Fig 4

Black full circles: fluid particles; red full circles: solid particle; bold black line: wall. a) Time instant r; b) time instant r+1.

In principle, the links between solid particles were set not to change in time, so that the i solid particle maintains the same neighboring p solid particles. Each pair of mass points i-p is connected via a spring having an elastic constant ke and a rest length l0,ip. In the model, the rest length of the spring is set equal to l0,ip=Δx2, as this choice was verified to lead to better numerical stability in the solutions. In fact, this distance corresponds to the average distance between the particles in the reference starting configuration, and to the distance that the particles tend to reach in any generic distribution when thrombus starts to form. In order to reach and preserve the rest length, the springs respond by applying internal forces. Indicating with lip the instantaneous updated distances from the i solid particle to the neighboring solid particles, the total internal force per unit mass acting on i, fi, can be expressed as

fi=keΔxmip=1Npl0,ip-lipx^ip (21)

where the summation is extended to the total number Np of solid particles connected to i and x^ip=xi-xp/lip is the unit vector directed from i to p.

The force fi is introduced in the momentum equation as body force per unit mass. Specifically, in the context of the ISPH approach, fi is added in the predictor step Eq 2.

In order to handle the elastic deformation of the thrombus, a relationship between the spring constant ke and the structure mechanical properties was obtained using a procedure described by Monteleone et al. [55]. Specifically, a solid cube discretised with SPH particles bounded with springs was used to perform a tension stress analysis. In the test, several ke values were investigated and the associated Young’s modulus E of the material was measured. As a result, a basic linear relationship between the spring coefficient and the Young’s modulus was identified, where ke/E = 6.31.

Moreover, the solid particles having distance to the boundary less than Δx/2 are linked to the wall through a spring to model the adhesion of the thrombus to the vessel. In Fig 4b, the solid particle E has a distance dEw < Δx/2 and thus it is connected to the wall.

In this study, potential thrombus dissolution is allowed through a procedure similar to that proposed by Tosenberger et al. [56] to model platelets adhesion. In particular, once the spring forms, it can be stretched up to a threshold distance lmax (corresponding to a limit local force), beyond which the link between the two particles is removed. Therefore, single particles or groups of particles bonded together can separate from the main thrombus and embolise. In Fig 5 the length of the spring connecting the particles A and C become larger that lmax and thus the tie is removed. Since the spring connecting C and F is still active, and the clot including particles C and F is now detached from the main thrombus and can be carried by the flow and expand recruiting other particles from the fluid.

Fig 5. Sketch of the solid particle separation.

Fig 5

Black full circles: fluid particles; red full circles: solid particle; bold black line: wall.

A flow-chart providing a step by step description of the implemented thrombus formation model is reported in Fig 6. The actions indicated in the flow chart are briefly explained in the following:

Fig 6. Flow-chart of the proposed thrombus formation model.

Fig 6

  • ACTION 1 –Source term: The source terms of the modelled species (pt, th, fg, fi, rp, ap and bp) to be introduced in the convection-diffusion equation are determined for each particle according to Eqs 915;

  • ACTION 2 –Species concentration: The concentration of the modelled species is calculated for each particle through the convection-diffusion Eq 7;

  • ACTION 3 –Internal solid forces: For each solid particle, the total force resulting from the system of neighbouring springs is calculated through Eq 21;

  • ACTION 4 –Predictor step: In this step, Eq 2 is solved to calculate the intermediate velocity u*. For the solid particles, the force calculated at ACTION 3 is added to Eq 2;

  • ACTION 5 –PPE system: The pseudo-pressure ψ is calculated solving the system made up of one PPE (Eq 4) for each particle;

  • ACTION 6 –Corrector step: In this step, the intermediate velocities are corrected obtaining the updated velocities (Eq 5);

  • ACTION 7 –Update particle position: After calculating the updated velocity field, the particles are moved. The updated position xir+1 can be obtained using the mean value of the new and old velocities (uir+1 and uir, respectively);

  • ACTION 8 –Generate mirror particles: The mirror particles are generated and the boundary conditions for the modelled species are imposed, as discussed in section 3.2;

  • ACTION 9 –Update particle support domain: The support domain of each particle is determined including all the surrounding particles with distance lower than kh;

  • ACTION 10—Identify solid particles: For each fluid particle, it is checked if the concentration of bound platelets exceeds the imposed threshold value. If this condition occurs, the particle is treated as solid and its list of neighbouring solid particles is created. Moreover, for each solid particle, the list of springs is updated during the simulation to bind new neighbours solid particles or to unbind particles that have exceeded the set distance threshold (lmax). The last condition is used to model potential thrombus dissolution.

  • ACTION 11 –Identify wall-bound particles: The solid particles to be linked to the wall are identified. To this aim, the distance from the wall is determined and if it is less than Δx⁄2, a bond with the wall is introduced.

After ACTION 11, the simulation time is advanced by one time step (t = t+dt), and the procedure is reiterated from ACTION 1.

4. Results and discussion

4.1 Thrombus formation in backward facing step

To validate the proposed thrombus model, the case study proposed by Taylor et al. [41] was replicated, where the thrombus growth was analysed in a Backward-facing step (BFS). BFS configurations are often employed to analyse phenomena where the presence of flow separation and reattachment regions is a leading factor [57]. In fact, these geometries are easy to adapt to the different engineering problems, thanks to the direct control on the fluid domain by parameters such as the Reynolds number and the geometrical dimensions of the channel and step. The BFS geometry and dimensions selected by Taylor et al. [41] are represented in Fig 7.

Fig 7. Backward facing step scheme.

Fig 7

Boundary Conditions imposed; Geometry and dimension: s = 2.5 mm; Ø = 10 mm; l = 20 mm; L = 100 mm.

In the simulation, the kernel width was set to 0.7 mm, resulting in a total of 215,000 particles. A flow rate of 0.76 l/min was imposed at the inlet section, whilst zero pressure was set at the outflow section (see Fig 7). In this study, the procedure described in Monteleone et al. [46] is used to handle open boundaries. This ensures mass conservation through the introduction of new particles in the computational domain, through the inflow section, balancing the particles which leave it through the outlet. Blood was modelled as a Newtonian fluid (the shear-thinning behaviour and yielding was neglected [58]), with density and dynamic viscosity equal to 1,060 kg/m3 and 0.0035 Pa s, respectively. The resulting Reynolds’ number was equal to 460, well within the laminar flow regimen.

In the numerical analysis, the parallel scheme of Monteleone et al. [59] was employed to save computational costs.

A preliminary hydrodynamic analysis was performed on the steady-state simulation without thrombus model (see Fig 8), to identify the recirculation region, obtaining a reattachment length equal to 17 mm, about 6.8 times the step height, consistently with Taylor et al. [41].

Fig 8. Streamwise particle velocity [m/s] in BFS without thrombus.

Fig 8

An enlargement of the region near the step is highlighted with the velocity vectors.

As previously described, the formation of blood clots is regulated by a complex cascade of biochemical reactions taking place on the surface of a growing thrombus. The transport of enzymes in the coagulation is reported to be dominated by convection phenomena in the bulk, whilst becomes diffusion-dominated in the zones characterised by low velocities [15]. Flow can both promote and limit thrombin generation and thrombus formation; and this behaviour makes its prediction a challenging task.

Recent investigations [60, 61] have indicated that thrombin generation is modified by variations in shear strain rate (SSR) and, in particular, its presence reduces where SSR is high. Due to the multi-scale nature of the problem, some strategies were used to speed up the computation. In the presented model, the SSR parameter was selected to amplify the different behaviour between bulk region and low velocity zones. Specifically, as described in section 3.2, since thrombin is selected as trigger factor, an amplification value equal to 105 was employed for the diffusive coefficient and source term of thrombin. Moreover, this coefficient was related to the SSR by applying it to particles having SSR lower that an imposed threshold value. Due to the accelerated conversion of thrombin, a continuous supply of the inactive biochemicals (pt and fg) and resting platelets was imposed.

The concentrations of the modeled species were initialised in the bulk through a steady-state simulation imposing the typical values in healthy human blood (as reported in Table 1) except for the concentrations of thrombin, fibrin and bound platelet, that were set to zero. Moreover, an initial concentration of activated platelets was considered to simulate primary hemostasis. This value is equal to 5% of the background concentration of resting platelets, consistently with the recommendation from Sarrami-Foroushani et al. [4].

The biochemical reaction kinetic constants and the threshold value for the thrombin used in the simulation are reported in Table 1. A Young’s modulus equal to 200 Pa (defined through the linear relationship between the Young’s modulus and the spring constant ke described in section 3.3) was used in the analysis to simulate the early stage of the thrombus formation.

In this study, the threshold distance lmax considered for the springs dissolution (as discussed in section 3.3) was set equal to 1.1 kh, as this value was found to lead to improved numerical stability and better correlation with experimental findings [41]. The trigger factor condition was imposed at the middle point of the step corner, as indicated in Fig 7, with a concentration of thrombin at the injured wall equal to the threshold value for thrombin amplified with the factor specified above (Cw,th=105Cth*).

A qualitative analysis was performed to evaluate the best match value of the SSR threshold. Fig 9 illustrates a comparison in the shape taken by the simulated thrombus for four different values. As it can be observed, using a SSR threshold equal to 10 s-1 (as recommended by Menichini and Xu [15]) the thrombus front is about triangular, with shape and dimensions that well resemble the experimental results described by Taylor et al. [41] (see Fig 10b).

Fig 9. Numerical results of thrombi formed (final time) considering various SSR threshold.

Fig 9

A) 40 s-1; B) 30 s-1; C) 20 s-1; D) 10 s-1.

Fig 10. Thrombus growth within the BFS.

Fig 10

a) Numerical results of FSI monolithic approach; b) Experimental results of [41] shown for comparison. Adapted from Taylor et al. [41] Copyright © 2014 ASME.

The temporal evolution of thrombus, in terms of formation and growth, is represented in Fig 10. The thrombus formation increases in both the radial and axial directions. Initially, the thrombus height reaches the step height (2.5 mm), while the maximum thrombus length achieved is equal to ten times the step height (25 mm). This is in agreement with the experimental results observed by Taylor et al. [41].

To assess the robustness and efficiency of the FSI monolithic method, the velocity field in the close proximity of the thrombus was examined. As shown in Fig 11, the thrombus growth is totally enclosed within the initial recirculation region, which eventually becomes entirely occupied by blood clotting.

Fig 11. Effect of thrombus formation on the velocity field in the vicinity of the step.

Fig 11

The velocity profile at a cross-section positioned at an axial distal distance from the step equal to 8 mm, is plotted in Fig 12 at three time instants. The diagrams show the temporal decrease of velocity as the thrombus propagates and approaches the cross section, as described in Fig 11.

Fig 12. Axial velocity profile at three time instants with a zoom of the region close to the step.

Fig 12

Continuous line: velocity at time zero; dotted line: time 0.5 s; dashed line: time 1 s.

This confirms the mutual interaction between hydrodynamic variables and blood clotting. Furthermore, the observed thrombus length reaches an asymptotic value that relates to the reattachment length of the initial recirculation region. It should be noted that, exceeding this asymptotic length, as the clot increases downstream the step it is dragged due to high velocity field. Therefore, although particles reach the conditions at which they can become solid, they cannot bind to the main thrombus, which maintains its size. The thrombus lysis is simulated using only maximum distances (as discussed in section 3.3). Correlation with the maximum fibrin concentration might reproduce the process more realistically, and may be incorporated in the code in a future iteration.

An analysis of the species concentration is shown in Fig 13. Considering three time instants (indicated as t1, t2 and t3 in the figure), the modelled active biochemical species (thrombin and fibrin) and platelets are triggered starting from the step position (see Fig 7) and spread downstream the channel.

Fig 13. Biochemical specie concentration map (logarithmic scale) at three time instants: t1 = 0.5 s; t2 = 1.5 s; t3 = 3 s.

Fig 13

The time evolution for the concentrations of the considered clotting factors were analysed at five different points in the recirculation region. These points are indicated in Fig 14. Points are positioned in the plane of symmetry, evenly spaced with pace equal to d (where d is the step height), with the first point i located at a distance equal to −d/2 from the step. The concentrations are calculated by averaging the values of particles lying at distance less than kh from the considered central point. The graphs in Fig 15 show that all concentrations increase gradually until they reach an asymptotic value. Thrombin (Fig 15a) starts from a high value at point i as a consequence of the trigger factor imposed at the step, whist the other points (ii to v) have an initial null value. A similar trend is highlighted in Fig 15b for fibrin evolution. Activated platelets (Fig 15c) have an initial value equal to 1013 PLT/m3, which steeply increases after about 0.5 s at points ii to v, as the activation function Ω becomes greater than 1 (see Eq 16). Since bound platelets are dependent on the activated platelets and fibrin mesh concentrations, their concentration follows the same development as represented in Fig 15d. The concentration analysis of the coagulative players of the thrombus formation process could be a helpful tool to individuate the regions involved by major risk stopping the main trigger factors.

Fig 14. Location of the measurement points used to evaluate the mean concentration of each specie.

Fig 14

Fig 15. Time evolution of the selected clotting factors considering five different points (see Fig 14).

Fig 15

Black continuous line: point A; red dotted line: point B; blue dashed line: point C; magenta dashed line: point D; green dashed dotted line: point E. Plotted used logarithmic scale in concentration axis.

5. Conclusions

The presented method is able to realistically describe the thrombosis phenomenon, including blood clotting variables (platelets, coagulative cascade enzymes), hydrodynamic parameters (shear strain rate and velocity) and mutual interactions between fluid dynamics of blood and the forming thrombus.

Differently from the partitioned FSI approach, in the proposed technique, no interface is requested and an intrinsic coupling between fluid and solid phases is performed saving computational costs. Thanks to this feature, future developments will be addressed to encompass the effect of tissues deformation which are key aspects in the cardiovascular field. Moreover, the method here presented, exploiting the advantage of a Lagrangian meshfree particle method like SPH, could become very suitable to handle complex geometries of patient-specific models, such as left atrial appendages, heart valves and stenoses, where a complete understanding of the process is essential to predict the risk of thrombosis diseases. Furthermore, as a consequence of its simplicity and flexibility, the approach can be implemented into a new tool supporting the design of safer and more effective medical devices.

Data Availability

All relevant data are within the paper.

Funding Statement

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Hosseinzadegan H, Tafti DK. Prediction of Thrombus Growth: Effect of Stenosis and Reynolds Number. Cardiovasc Eng Technol. 2017;8: 164–181. doi: 10.1007/s13239-017-0304-3 [DOI] [PubMed] [Google Scholar]
  • 2.Stiefel M, Shaner A, Schaefer SD. The Edwin Smith Papyrus: The Birth of Analytical Thinking in Medicine and Otolaryngology. Laryngoscope. 2006;116: 182–188. doi: 10.1097/01.mlg.0000191461.08542.a3 [DOI] [PubMed] [Google Scholar]
  • 3.Virchow R. Gesammelte abhandlungen zur wissenschaftlichen medicin.tle. Frankfurt: Meidinger; 1856. [Google Scholar]
  • 4.Sarrami-Foroushani A, Lassila T, Hejazi SM, Nagaraja S, Bacon A, Frangi AF. A computational model for prediction of clot platelet content in flow-diverted intracranial aneurysms. J Biomech. 2019;91: 7–13. doi: 10.1016/j.jbiomech.2019.04.045 [DOI] [PubMed] [Google Scholar]
  • 5.Sangkuhl K, Shuldiner AR, Klein TE, Altman RB. Platelet aggregation pathway. Pharmacogenet Genomics. 2011;21: 516–521. doi: 10.1097/FPC.0b013e3283406323 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Koupenova M, Kehrel BE, Corkrey HA, Freedman JE. Thrombosis and platelets: an update. Eur Heart J. 2016; ehw550. doi: 10.1093/eurheartj/ehw550 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Cito S, Mazzeo MD, Badimon L. A Review of Macroscopic Thrombus Modeling Methods. Thromb Res. 2013;131: 116–124. doi: 10.1016/j.thromres.2012.11.020 [DOI] [PubMed] [Google Scholar]
  • 8.Zhang P, Zhang L, Slepian MJ, Deng Y, Bluestein D. A multiscale biomechanical model of platelets: Correlating with in-vitro results. J Biomech. 2017;50: 26–33. doi: 10.1016/j.jbiomech.2016.11.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Gao C, Zhang P, Bluestein D. Multiscale Modeling of Mechanotransduction Processes in Flow-Induced Platelet Activation. 2016 IEEE 2nd International Conference on Big Data Security on Cloud (BigDataSecurity), IEEE International Conference on High Performance and Smart Computing (HPSC), and IEEE International Conference on Intelligent Data and Security (IDS). IEEE; 2016. pp. 274–279.
  • 10.Xu Z, Zou Q. A Molecular Dynamics Based Multi-scale Platelet Aggregation Model and Its High-Throughput Simulation. 2022. pp. 81–92. doi: 10.1007/978-3-030-96772-7_8 [DOI] [Google Scholar]
  • 11.Bodnár T, Sequeira A. Numerical Simulation of the Coagulation Dynamics of Blood. Comput Math Methods Med. 2008;9: 83–104. doi: 10.1080/17486700701852784 [DOI] [Google Scholar]
  • 12.Sorensen EN, Burgreen GW, Wagner WR, Antaki JF. Computational Simulation of Platelet Deposition and Activation: I. Model Development and Properties. Ann Biomed Eng. 1999;27: 436–448. doi: 10.1114/1.200 [DOI] [PubMed] [Google Scholar]
  • 13.Leiderman K, Fogelson AL. Grow with the flow: a spatial-temporal model of platelet deposition and blood coagulation under flow. Mathematical Medicine and Biology. 2011;28: 47–84. doi: 10.1093/imammb/dqq005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Anand M, Rajagopal K, Rajagopal KR. A Model for the Formation and Lysis of Blood Clots. Pathophysiol Haemost Thromb. 2005;34: 109–120. doi: 10.1159/000089931 [DOI] [PubMed] [Google Scholar]
  • 15.Menichini C, Xu XY. Mathematical modeling of thrombus formation in idealized models of aortic dissection: initial findings and potential applications. J Math Biol. 2016;73: 1205–1226. doi: 10.1007/s00285-016-0986-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Vella D, Monteleone A, Musotto G, Bosi GMGM, Burriesci G. Effect of the Alterations in Contractility and Morphology Produced by Atrial Fibrillation on the Thrombosis Potential of the Left Atrial Appendage. Front Bioeng Biotechnol. 2021;9: 147. doi: 10.3389/fbioe.2021.586041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Musotto G, Monteleone A, Vella D, di Leonardo S, Viola A, Pitarresi G, et al. The Role of Patient-Specific Morphological Features of the Left Atrial Appendage on the Thromboembolic Risk Under Atrial Fibrillation. 2022;9: 1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Farhat C, Lesoinne M. Two efficient staggered algorithms for the serial and parallel solution of three-dimensional nonlinear transient aeroelastic problems. Comput Methods Appl Mech Eng. 2000;182: 499–515. doi: 10.1016/S0045-7825(99)00206-6 [DOI] [Google Scholar]
  • 19.Souli M, Ouahsine A, Lewin L. ALE formulation for fluid–structure interaction problems. Comput Methods Appl Mech Eng. 2000;190: 659–675. doi: 10.1016/S0045-7825(99)00432-6 [DOI] [Google Scholar]
  • 20.Kuhl E, Hulshoff S, de Borst R. An arbitrary Lagrangian Eulerian finite-element approach for fluid-structure interaction phenomena. Int J Numer Methods Eng. 2003;57: 117–142. doi: 10.1002/nme.749 [DOI] [Google Scholar]
  • 21.Lipari G, Napoli E. The impacts of the ALE and hydrostatic-pressure approaches on the energy budget of unsteady free-surface flows. Comput Fluids. 2008;37: 656–673. doi: 10.1016/j.compfluid.2007.10.005 [DOI] [Google Scholar]
  • 22.Peskin CS. The immersed boundary method. Acta Numerica. 2002;11: 479–517. doi: 10.1017/S0962492902000077 [DOI] [Google Scholar]
  • 23.Th Dunne. An Eulerian approach to fluid–structure interaction and goal-oriented mesh adaptation. Int J Numer Methods Fluids. 2006;51: 1017–1039. doi: 10.1002/fld.1205 [DOI] [Google Scholar]
  • 24.Richter T. A Fully Eulerian formulation for fluid–structure-interaction problems. J Comput Phys. 2013;233: 227–240. doi: 10.1016/j.jcp.2012.08.047 [DOI] [Google Scholar]
  • 25.Fan J, Liao H, Ke R, Kucukal E, Gurkan UA, Shen X, et al. A monolithic Lagrangian meshfree scheme for Fluid–Structure Interaction problems within the OTM framework. Comput Methods Appl Mech Eng. 2018;337: 198–219. doi: 10.1016/j.cma.2018.03.031 [DOI] [Google Scholar]
  • 26.Ryzhakov PB, Rossi R, Idelsohn SR, Oñate E. A monolithic Lagrangian approach for fluid–structure interaction problems. Comput Mech. 2010;46: 883–899. doi: 10.1007/s00466-010-0522-0 [DOI] [Google Scholar]
  • 27.Franci A, Oñate E, Carbonell JM. Unified Lagrangian formulation for solid and fluid mechanics and FSI problems. Comput Methods Appl Mech Eng. 2016;298: 520–547. doi: 10.1016/j.cma.2015.09.023 [DOI] [Google Scholar]
  • 28.Morikawa DS, Asai M. Coupling total Lagrangian SPH–EISPH for fluid–structure interaction with large deformed hyperelastic solid bodies. Comput Methods Appl Mech Eng. 2021;381: 113832. doi: 10.1016/j.cma.2021.113832 [DOI] [Google Scholar]
  • 29.Antoci C, Gallati M, Sibilla S. Numerical simulation of fluid–structure interaction by SPH. Comput Struct. 2007;85: 879–890. doi: 10.1016/j.compstruc.2007.01.002 [DOI] [Google Scholar]
  • 30.Tsubota K, Sughimoto K, Okauchi K, Liu H. Particle Method Simulation of Thrombus Formation in Fontan Route. 2016. pp. 387–396.
  • 31.Masalceva AA, Kaneva VN, Panteleev MA, Ataullakhanov F, Volpert V, Afanasyev I, et al. Analysis of microvascular thrombus mechanobiology with a novel particle-based model. J Biomech. 2022;130: 110801. doi: 10.1016/j.jbiomech.2021.110801 [DOI] [PubMed] [Google Scholar]
  • 32.Wang F, Xu S, Jiang D, Zhao B, Dong X, Zhou T, et al. Particle hydrodynamic simulation of thrombus formation using velocity decay factor. Comput Methods Programs Biomed. 2021;207: 106173. doi: 10.1016/j.cmpb.2021.106173 [DOI] [PubMed] [Google Scholar]
  • 33.Wang L, Chen Z, Zhang J, Zhang X, Wu ZJ. Modeling Clot Formation of Shear-Injured Platelets in Flow by a Dissipative Particle Dynamics Method. Bull Math Biol. 2020;82: 83. doi: 10.1007/s11538-020-00760-9 [DOI] [PubMed] [Google Scholar]
  • 34.Toma M. The Emerging Use of SPH In Biomedical Applications. Significances of Bioengineering & Biosciences. 2017;1. doi: 10.31031/SBB.2017.01.000502 [DOI] [Google Scholar]
  • 35.Shahriari S, Kadem L. Smoothed Particle Hydrodynamics Method and Its Applications to Cardiovascular Flow Modeling. Numerical Methods and Advanced Simulation in Biomechanics and Biological Processes. Elsevier; 2018. pp. 203–219.
  • 36.Chui Y-P, Heng P-A. A meshless rheological model for blood-vessel interaction in endovascular simulation. Prog Biophys Mol Biol. 2010;103: 252–261. doi: 10.1016/j.pbiomolbio.2010.09.003 [DOI] [PubMed] [Google Scholar]
  • 37.Al-Saad M, Suarez CA., Obeidat A, Bordas S P. A., Kulasegaram S. Application of Smooth Particle Hydrodynamics Method for Modelling Blood Flow with Thrombus Formation. Computer Modeling in Engineering & Sciences. 2020;122: 831–862. doi: 10.32604/cmes.2020.08527 [DOI] [Google Scholar]
  • 38.Ariane M, Vigolo D, Brill A, Nash FGB, Barigou M, Alexiadis A. Using Discrete Multi-Physics for studying the dynamics of emboli in flexible venous valves. Comput Fluids. 2018;166: 57–63. doi: 10.1016/j.compfluid.2018.01.037 [DOI] [Google Scholar]
  • 39.Baksamawi HA, Ariane M, Brill A, Vigolo D, Alexiadis A. Modelling Particle Agglomeration on through Elastic Valves under Flow. ChemEngineering. 2021;5: 40. doi: 10.3390/chemengineering5030040 [DOI] [Google Scholar]
  • 40.Napoli E, de Marchis M, Vitanza E. PANORMUS-SPH. A new Smoothed Particle Hydrodynamics solver for incompressible flows. Comput Fluids. 2015;106: 185–195. doi: 10.1016/j.compfluid.2014.09.045 [DOI] [Google Scholar]
  • 41.Taylor JO, Witmer KP, Neuberger T, Craven BA, Meyer RS, Deutsch S, et al. In Vitro Quantification of Time Dependent Thrombus Size Using Magnetic Resonance Imaging and Computational Simulations of Thrombus Surface Shear Stresses. J Biomech Eng. 2014;136. doi: 10.1115/1.4027613 [DOI] [PubMed] [Google Scholar]
  • 42.Wendland H. Piecewise polynomial, positive definite and compactly supported radial functions of minimal degree. Adv Comput Math. 1995;4: 389–396. doi: 10.1007/BF02123482 [DOI] [Google Scholar]
  • 43.Napoli E, de Marchis M, Gianguzzi C, Milici B, Monteleone A. A coupled Finite Volume–Smoothed Particle Hydrodynamics method for incompressible flows. Comput Methods Appl Mech Eng. 2016;310: 674–693. doi: 10.1016/j.cma.2016.07.034 [DOI] [Google Scholar]
  • 44.Monteleone A, de Marchis M, Milici B, Napoli E. A multi-domain approach for smoothed particle hydrodynamics simulations of highly complex flows. Comput Methods Appl Mech Eng. 2018;340: 956–977. doi: 10.1016/j.cma.2018.06.029 [DOI] [Google Scholar]
  • 45.Chorin AJ. Numerical solution of the Navier-Stokes equations. Math Comput. 1968;22: 745–762. doi: 10.1090/S0025-5718-1968-0242392-2 [DOI] [Google Scholar]
  • 46.Monteleone A, Monteforte M, Napoli E. Inflow/outflow pressure boundary conditions for smoothed particle hydrodynamics simulations of incompressible flows. Comput Fluids. 2017;159. doi: 10.1016/j.compfluid.2017.09.011 [DOI] [Google Scholar]
  • 47.Ernst Hairer, Gerhard Wanner SPN. Solving Ordinary Differential Equations I. 978-3-540-78862-1
  • 48.Rosing J, van Rijn J, Bevers E, van Dieijen G, Comfurius P, Zwaal R. The role of activated human platelets in prothrombin and factor X activation. Blood. 1985;65: 319–332. doi: 10.1182/blood.V65.2.319.319 [DOI] [PubMed] [Google Scholar]
  • 49.Michaelis L, Menten ML. Die kinetik der invertinwirkung. Biochem z. 1913;49: 352. [Google Scholar]
  • 50.Weiss HJ. Platelets: Pathophysiology and Antiplatelet Drug Therapy. Liss. 1982.
  • 51.IB P. Mathematical modeling in systems biology: an introduction. Choice Reviews Online. 2014;51: 51-3830-51–3830. doi: 10.5860/CHOICE.51-3830 [DOI] [Google Scholar]
  • 52.Grunkemeier JM, Tsai WB, Horbett TA. Hemocompatibility of treated polystyrene substrates: Contact activation, platelet adhesion, and procoagulant activity of adherent platelets. J Biomed Mater Res. 1998;41: 657–670. doi: 10.1002/(sici)1097-4636(19980915)41:4&lt;657::aid-jbm18&gt;3.0.co;2-b [DOI] [PubMed] [Google Scholar]
  • 53.Anand M, Rajagopal K, Rajagopal KR. A Model Incorporating Some of the Mechanical and Biochemical Factors Underlying Clot Formation and Dissolution in Flowing Blood. Journal of Theoretical Medicine. 2003;5: 183–218. doi: 10.1080/10273660412331317415 [DOI] [Google Scholar]
  • 54.Tsiang M, Paborsky LR, Li W-X, Jain AK, Mao CT, Dunn KE, et al. Protein Engineering Thrombin for Optimal Specificity and Potency of Anticoagulant Activity in Vivo. Biochemistry. 1996;35: 16449–16457. doi: 10.1021/bi9616108 [DOI] [PubMed] [Google Scholar]
  • 55.Monteleone A, Borino G, Napoli E, Burriesci G. Fluid–structure interaction approach with smoothed particle hydrodynamics and particle–spring systems. Comput Methods Appl Mech Eng. 2022;392: 114728. 10.1016/j.cma.2022.114728 [DOI] [Google Scholar]
  • 56.Tosenberger A, Ataullakhanov F, Bessonov N, Panteleev M, Tokarev A, Volpert V. Modelling of platelet–fibrin clot formation in flow with a DPD–PDE method. J Math Biol. 2016;72: 649–681. doi: 10.1007/s00285-015-0891-2 [DOI] [PubMed] [Google Scholar]
  • 57.Armaly BF, Durst F, Pereira JCF, Schönung B. Experimental and theoretical investigation of backward-facing step flow. J Fluid Mech. 1983;127: 473. doi: 10.1017/S0022112083002839 [DOI] [Google Scholar]
  • 58.Cho YI, Cho DJ, Rosenson RS. Endothelial Shear Stress and Blood Viscosity in Peripheral Arterial Disease. Curr Atheroscler Rep. 2014;16: 404. doi: 10.1007/s11883-014-0404-6 [DOI] [PubMed] [Google Scholar]
  • 59.Monteleone A, Burriesci G, Napoli E. A distributed-memory MPI parallelization scheme for multi-domain incompressible SPH. J Parallel Distrib Comput. 2022;170: 53–67. doi: 10.1016/j.jpdc.2022.08.004 [DOI] [Google Scholar]
  • 60.Link KG, Stobb MT, di Paola J, Neeves KB, Fogelson AL, Sindi SS, et al. A local and global sensitivity analysis of a mathematical model of coagulation and platelet deposition under flow. Garcia de Frutos P, editor. PLoS One. 2018;13: e0200917. doi: 10.1371/journal.pone.0200917 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Bouchnita A, Volpert V. A multiscale model of platelet-fibrin thrombus growth in the flow. Comput Fluids. 2019;184: 10–20. doi: 10.1016/j.compfluid.2019.03.021 [DOI] [Google Scholar]

Decision Letter 0

Alessio Alexiadis

1 Dec 2022

PONE-D-22-30268Modelling of thrombus formation using smoothed particle hydrodynamics methodPLOS ONE

Dear Dr. Burriesci,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please revise your manuscript based on the Reviewers comments. I also invite the authors to highlight the novelty of their work, especially considering, as Reviewer 2 pointed out, that the authors were not aware of several articles published in the literature with subject similar to their manuscript.    

Please submit your revised manuscript by Jan 15 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Alessio Alexiadis

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1.  Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf  and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure:

“The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript”

At this time, please address the following queries:

a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.

b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c) If any authors received a salary from any of your funders, please state which authors and which funders.

d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

3. Thank you for stating the following in your Competing Interests section: 

“NO authors have competing interests”

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now

 This information should be included in your cover letter; we will change the online submission form on your behalf.

4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

Additional Editor Comments:

Please revise your manuscript based on the Reviewers comments

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: A SPH-based FSI method, combined with a species transport equation, is proposed to simulate thrombus formation. Equation (21) is then used to form new bonding pair.

The main novelty is on the proposal of platelet activation/concentration model (Eq 6) for various species. The fluid particle is switched to solid particle if the concentration reaches a threshold value.

I have a few comments:

Comments:

1. A flow chart detailing on the FSI method and its coupling with the concentration model (6) should be given.

2. There are various constants tabulated in Table 1. Some references were cited for each constant. Are these constants generic and universal to all flow circumstances? Please discuss.

3. The threshold values for platelet activation, as well as methods on how to determine them, are not detailed.

4. Eq (21), the spring constant ke, is not given and discussed. How to determine this spring constant ke for a specific flow case?

5. I wonder why a factor of root(2) is needed for the rest length expression. I presume that root(2) is needed for diagonal neighbours, but not others (horizontal and vertical neighbors). Please explain.

6. The numerical and experimental observations are compared in Figure 8. Please explain how to tune the constants in the species model & other spring constants (if tuning is performed) during the validation stage. The C*th value is not given in this case.

Reviewer #2: General comments :

I reviewed the article written by Monteleone et Al. The work entitled Modelling of thrombus formation using smoothed particle hydrodynamics method presents a sph approach including an agglomeration algorithm to simulate the hemodynamics and the solid blood accrual in the flow.

The aim of the study is to show that, with a single model, is possible to simulate blood flow and thrombosis formation including coagulative cascade.

Major comments:

The bibliographical section is incomplete. Indeed, for instance some relevant papers exploring this research field are not presented, such as (non exhaustive list) :

• Modelling Particle Agglomeration on through Elastic Valves under Flow Baksamawi, HA; Ariane, M; (...); Alexiadis, A

• Using Discrete Multi-Physics for studying the dynamics of emboli in flexible venous valves Ariane, M; Vigolo, D; (...); Alexiadis, A

• Modeling Clot Formation of Shear-Injured Platelets in Flow by a Dissipative Particle Dynamics Method. Liwei Wang, Zengsheng Chen, Jiafeng Zhang, Xiwen Zhang & Zhongjun J. Wu

• A multiscale biomechanical model of platelets: Correlating with in-vitro results By:Zhang, P (Zhang, Peng) [1] ; Zhang, L (Zhang, Li) [2] ; Slepian, MJ (Slepian, Marvin J.) [1] , [3] , [4] ; Deng, YF (Deng, Yuefan) [2] ; Bluestein, D (Bluestein, Danny) [1]

• Multiscale Modeling of Mechanotransduction Processes in Flow-Induced Platelet Activation By:Gao, C (Gao, Chao) [1] ; Zhang, P (Zhang, Peng) [1] ; Bluestein, D (Bluestein, Danny) [1]

• Particle Method Simulation of Thrombus Formation in Fontan Route By:Tsubota, K (Tsubota, Ken-ichi) [1] ; Sughimoto, K (Sughimoto, Koichi) [2] ; Okauchi, K (Okauchi, Kazuki) [1] ; Liu, H (Liu, Hao) [1]

• Analysis of microvascular thrombus mechanobiology with a novel particle-based model By:Masalceva, AA (Masalceva, Anastasia A.) [1] , [2] ; Kaneva, VN (Kaneva, Valeriia N.) [1] , [2] , [3] ; Panteleev, MA (Panteleev, Mikhail A.) [1] , [2] , [3] , [4] ; Ataullakhanov, F (Ataullakhanov, Fazoil) [1] , [2] , [3] , [4] ; Volpert, V (Volpert, Vitaly) [5] , [6] , [7] ; Afanasyev, I (Afanasyev, Ilya) [8] , [9] ; Nechipurenko, DY (Nechipurenko, Dmitry Yu) [1] , [2] ,

• A Molecular Dynamics Based Multi-scale Platelet Aggregation Model and Its High-Throughput Simulation By:Xu, ZP (Xu, Zhipeng) [1] ; Zou, QS (Zou, Qingsong) [2]

• Particle hydrodynamic simulation of thrombus formation using velocity decay factor. Wang F, Xu S, Jiang D, Zhao B, Dong X, Zhou T, Luo X.

Minor comments:

• Is there any convergence criterion for this simulation especially for the agglomeration algorithm? Or is it an open-loop computation?

• What kind of particle does the author use at inlet section, periodic condition (if so, are the particle properties reset after the loop) or new particles.

• Section 3.3. references are needed to support the following sentence (‘the species do not affect the blood velocity in normal conditions’)

• Last phrase before section 4. Should be developed (‘the thrombus dissolution …….thrombus and embolise’)

• Figure 6: velocity vectors are too small, I suggest using a constant length instead and including colors for values gradient.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Feb 6;18(2):e0281424. doi: 10.1371/journal.pone.0281424.r002

Author response to Decision Letter 0


11 Jan 2023

RESPONSE TO EDITOR

COMMENT:

I also invite the authors to highlight the novelty of their work, especially considering, as Reviewer 2 pointed out, that the authors were not aware of several articles published in the literature with subject similar to their manuscript.

RESPONSE:

We are glad that you confirm that the paper is generally well written, and we appreciate your comment, and all competent and constructive feedback from yourself and the reviewers, which have been stimulating and we feel that has strongly contributed to improve the quality of the manuscript. All the issues mentioned by the reviewers have been addressed and a point-by-point reply is provided for each of them.

We have highlighted the novelty of our work in the revised manuscript:

“This paper presents a new three-dimensional numerical method based on SPH for the simulation of thrombus formation. Contrary to previous works, the proposed approach efficiently combines the biomechanical and biochemical processes in the thrombosis phenomenon. Four biochemical species and three platelets states are considered to replicate the main phases of the coagulative cascade. A particle agglomeration/dissolution algorithm is proposed, able to model both thrombus formation and growth, as well as embolisation. The fluid-solid coupling is enforced through to the inclusion of elastic forces between solid particles, which are established by recruiting fluid particles when specific hydrodynamic and biochemical conditions are satisfied. An innovative monolithic FSI approach is developed to describe the interaction between blood and the forming thrombus using a single solver.”

We trust that you and the reviewers will now find the manuscript acceptable for publication in the Plos One.

We look forward to hearing from you at your earliest convenience.

_____________________________________________________________________________________________

RESPONSE TO REVIEWER #1

We wish to express our gratitude to Referee 1 for their detailed and constructive comments, that have allowed us to largely improve the quality of the manuscript. In the new version of the manuscript, all points raised by Referee 1 are addressed and discussed. A point-by-point reply follows, where the changes to the original manuscript are explicitly listed.

COMMENT 1.1:

A flow chart detailing on the FSI method and its coupling with the concentration model (6) should be given.

RESPONSE 1.1:

We appreciate the reviewer’s suggestion. In the new version of the manuscript we have added a flow-chart of the proposed thrombus formation model. The new sentences that have been added in the revised manuscript are reported below:

“A flow-chart providing a step by step description of the implemented thrombus formation model is reported in Fig 6. The actions indicated in the flow chart are briefly explained in the following:

• ACTION 1 – Source term: The source terms of the modelled species (pt, th, fg, fi, rp, ap and bp) to be introduced in the convection-diffusion equation are determined for each particle according to eqns. 9-15;

• ACTION 2 – Species concentration: The concentration of the modelled species is calculated for each particle through the convection-diffusion eqn. 7;

• ACTION 3 – Internal solid forces: For each solid particle, the total force resulting from the system of neighbouring springs is calculated through eqn. 21;

• ACTION 4 – Predictor step: In this step, eqn. 2 is solved to calculate the intermediate velocity 𝒖∗. For the solid particles, the force calculated at ACTION 3 is added to eqn. 2;

• ACTION 5 – PPE system: The pseudo-pressure 𝜓 is calculated solving the system made up of one PPE (eqn. 4) for each particle;

• ACTION 6 – Corrector step: In this step, the intermediate velocities are corrected obtaining the updated velocities (eqn. 5);

• ACTION 7 – Update particle position: After calculating the updated velocity field, the particles are moved. The updated position xir+1can be obtained using the mean value of the new and old velocities (uir+1 and uir, respectively);

• ACTION 8 – Generate mirror particles: The mirror particles are generated and the boundary conditions for the modelled species are imposed, as discussed in section 3.2;

• ACTION 9 – Update particle support domain: The support domain of each particle is determined including all the surrounding particles with distance lower than kh;

• ACTION 10 - Identify solid particles: For each fluid particle, it is checked if the concentration of bound platelets exceeds the imposed threshold value. If this condition occurs, the particle is treated as solid and its list of neighbouring solid particles is created. Moreover, for each solid particle, the list of springs is updated during the simulation to bind new neighbours solid particles or to unbind particles that have exceeded the set distance threshold (lmax). The last condition is used to model potential thrombus dissolution.

• ACTION 11 – Identify wall-bound particles: The solid particles to be linked to the wall are identified. To this aim, the distance from the wall is determined and if it is less than Δ𝑥2⁄, a bond with the wall is introduced.

After ACTION 11, the simulation time is advanced by one time step (t = t+dt), and the procedure is reiterated from ACTION 1.”

COMMENT 1.2:

There are various constants tabulated in Table 1. Some references were cited for each constant. Are these constants generic and universal to all flow circumstances? Please discuss.

RESPONSE 1.2:

Constants used in the proposed approach and summarised in Table 1 of the manuscript are taken from the literature, and obtained from experimental tests on blood [4,12,52-55]. These constants have been used in a number of studies from other groups to model different flow conditions. For example, in [12,54] thrombus formation is simulated under steady flow conditions, while in [4] the clot in an aneurysm is modelled in pulsatile blood condition. We have included the following discussion in the revised manuscript:

“The constants and parameters used in the model are obtained from experimental studies available in the literature [4,12,52-55]. These values, listed in Table 1, are general and applicable in different flow conditions [4,12].”

COMMENT 1.3:

The threshold values for platelet activation, as well as methods on how to determine them, are not detailed.

RESPONSE 1.3:

In the proposed model, the threshold value for the platelet activation is related to the thrombin concentration. In particular, we used the procedure proposed in [12], where the kinetic constant for the activated platelets kap is related to an activation function Ω through eqn. 16 of the manuscript.

In the expression of the activation function we assumed thrombin as the only agonist of the process (weigh 𝑤_𝑡ℎ = 1) with threshold concentration 𝐶*_𝑡ℎ = 9.11e-10 M and activation time t_act = 1, as recommended in [12,50].

Ω = 𝑤_𝑡ℎ 𝐶_𝑡ℎ / 𝐶*_𝑡ℎ.

In the proposed model, the conversion of resting platelets to activated platelets starts when the threshold concentration for thrombin is reached (𝐶_𝑡ℎ >= 𝐶*_𝑡ℎ) and thus the kinetic constant 𝑘_𝑎𝑝 in eqn. 16 of the manuscript becomes larger than 1.

We agree with the reviewer that including more details on the threshold value should be included in the manuscript. To cover this gap, the following description have been integrated in the section discussing the equation for the activation function:

“… where 𝑤_𝑡ℎ=1 and 𝐶*_𝑡ℎ is the threshold concentration for the thrombin. The latter was set equal to 9.11∙10^(-10) M, as recommended in the literature [12],[50] (see Table 1 of the manuscript). Therefore, conversion from resting to activated platelets is achieved when the concentration of the thrombin reaches the threshold value 𝐶*_𝑡ℎ”.

COMMENT 1.4:

Eq (21), the spring constant ke, is not given and discussed. How to determine this spring constant ke for a specific flow case?

RESPONSE 1.4:

The procedure to determine the spring constant is independent from the flow case. In particular, the relation between the spring coefficient k_e and the Young’s modulus E is determined following the technique implemented by group and detailed in [58]. Specifically, a cube of length L = 0.01 m was used to perform a tension stress analysis imposing a pressure of 10,000 Pa on the cube faces of normal direction z. All particles representing the cube were bounded with springs to simulate a solid behaviour. The Young’s modulus was thus obtained as the ratio of the imposed stress and the resulting strain in the z direction. The analysis was repeated to obtain a set of coefficients ke and the corresponding Young’s moduli. A linear relationship between the spring coefficient and the Young’s modulus was then identified (k_e/E = 6.31).

We agree with the reviewer that this point must be better clarified; therefore we have now included the following sentences in the revised manuscript:

“In order to handle the elastic deformation of the thrombus, a relationship between the spring constant ke and the structure mechanical properties was obtained using the procedure described by Monteleone et al. [58]. Specifically, a solid cube discretised with SPH particles bounded with springs was used to perform a tension stress analysis. In the test, several ke values were investigated and the associated Young’s modulus E of the material was measured. As a result, a basic linear relationship between the spring coefficient and the Young’s modulus was identified, where k_e/E = 6.31.”

COMMENT 1.5:

I wonder why a factor of root(2) is needed for the rest length expression. I presume that root(2) is needed for diagonal neighbours, but not others (horizontal and vertical neighbors). Please explain.

RESPONSE 1.5:

We agree with the reviewer that the use of the square root for the rest length expression must be better explained. In the model, we use an average distance for the rest length expression. This was found to give solutions with better numerical stability. In particular, in the starting configuration the particles are arranged at an isotropic initial distance Δ𝑥, that in this study was assumed equal to the smoothing length h. In this configuration, a generic i particle, has a total of 26 particles in its support domain: 6 particles with distance Δ𝑥, 12 particles with distance Δ𝑥 sqrt(2) and 8 particles with distance Δ𝑥 sqrt(3). The mean distance is thus equal to Δ𝑥 sqrt(2). In a general configuration, such as that present at the thrombus formation, the particles are not distributed anymore in a regular way as in the reference configuration, but it is observed that they globally tend to reach this average distance.

In order to clarify that point, we have added the following sentences in the revised manuscript:

“In the model, the rest length of the spring is set equal to 𝑙_0, 𝑖𝑝 = Δ𝑥 √2, as this choice was verified to lead to better numerical stability in the solutions. In fact, this distance corresponds to the average distance between the particles in the reference starting configuration, and to the distance that the particles tend to reach in any generic distribution when thrombus starts to form.”

COMMENT 1.6:

The numerical and experimental observations are compared in Figure 8. Please explain how to tune the constants in the species model & other spring constants (if tuning is performed) during the validation stage. The 𝐶*_𝑡ℎ value is not given in this case.

RESPONSE 1.6:

The constant species and the 𝐶*_𝑡ℎ value used in the validation test are reported in Table 1 of the manuscript. These values are constant, and no tuning procedure was performed to calibrate them. Similarly, as explained in response to COMMENT 1.4 of this document, the spring constant k_e is fixed and related to the Young’s modulus E through the relation k_e/E = 6.31. In particular, a Young’s modulus of 200 Pa was used in the simulation to model the early stage of the thrombus formation. We agree with the reviewer that this needs to be better clarified in the manuscript, where we have added the following sentences:

“The biochemical reaction kinetic constants and the threshold value for the thrombin used in the simulation are summarised in Table 1. A Young’s modulus equal to 200 Pa (defined through the linear relationship between the Young’s modulus and the spring constant ke described in section 3.3) was used in the analysis to simulate the early stage of the thrombus formation.”

REFERENCES

[4] Sarrami-Foroushani A, Lassila T, Hejazi SM, Nagaraja S, Bacon A, Frangi AF. A computational model for prediction of clot platelet content in flow-diverted intracranial aneurysms. J Biomech. 2019;91: 7–13. doi:10.1016/j.jbiomech.2019.04.045

[12] Sorensen EN, Burgreen GW, Wagner WR, Antaki JF. Computational Simulation of Platelet Deposition and Activation: I. Model Development and Properties. Ann Biomed Eng. 1999;27: 436–448. doi:10.1114/1.200

[50] Weiss HJ. Platelets: Pathophysiology and Antiplatelet Drug Therapy. Liss. 1982.

[52] Grunkemeier JM, Tsai WB, Horbett TA. Hemocompatibility of treated polystyrene substrates: Contact activation, platelet adhesion, and procoagulant activity of adherent platelets. J Biomed Mater Res. 1998;41: 657–670. doi:10.1002/(SICI)1097-4636(19980915)41:4<657::AID-JBM18>3.0.CO;2-B

[53] Rosing J, van Rijn J, Bevers E, van Dieijen G, Comfurius P, Zwaal R. The role of activated human platelets in prothrombin and factor X activation. Blood. 1985;65: 319–332. doi:10.1182/blood.V65.2.319.319

[54] Anand M, Rajagopal K, Rajagopal KR. A Model Incorporating Some of the Mechanical and Biochemical Factors Underlying Clot Formation and Dissolution in Flowing Blood. Journal of Theoretical Medicine. 2003;5: 183–218. doi:10.1080/10273660412331317415

[55] Tsiang M, Paborsky LR, Li W-X, Jain AK, Mao CT, Dunn KE, et al. Protein Engineering Thrombin for Optimal Specificity and Potency of Anticoagulant Activity in Vivo. Biochemistry. 1996;35: 16449–16457. doi:10.1021/bi9616108

[58] Monteleone A, Borino G, Napoli E, Burriesci G. Fluid–structure interaction approach with smoothed particle hydrodynamics and particle–spring systems. Comput Methods Appl Mech Eng. 2022;392: 114728. doi:https://doi.org/10.1016/j.cma.2022.114728

_____________________________________________________________________________

RESPONSE TO REVIEWER #2

We wish to express our gratitude to Referee 2 for his/her detailed and constructive comments, that have allowed us to largely improve the quality of the manuscript. In the new version of the manuscript, all points raised by Referee 2 are addressed and discussed. A point-by-point reply follows, where the changes to the original manuscript are explicitly listed.

MAJOR COMMENTS:

The bibliographical section is incomplete. Indeed, for instance some relevant papers exploring this research field are not presented, such as (non exhaustive list) :

• Modelling Particle Agglomeration on through Elastic Valves under Flow Baksamawi, HA; Ariane, M; (...); Alexiadis, A

• Using Discrete Multi-Physics for studying the dynamics of emboli in flexible venous valves Ariane, M; Vigolo, D; (...); Alexiadis, A

• Modeling Clot Formation of Shear-Injured Platelets in Flow by a Dissipative Particle Dynamics Method. Liwei Wang, Zengsheng Chen, Jiafeng Zhang, Xiwen Zhang & Zhongjun J. Wu

• A multiscale biomechanical model of platelets: Correlating with in-vitro results By:Zhang, P (Zhang, Peng) [1] ; Zhang, L (Zhang, Li) [2] ; Slepian, MJ (Slepian, Marvin J.) [1] , [3] , [4] ; Deng, YF (Deng, Yuefan) [2] ; Bluestein, D (Bluestein, Danny) [1]

• Multiscale Modeling of Mechanotransduction Processes in Flow-Induced Platelet Activation By:Gao, C (Gao, Chao) [1] ; Zhang, P (Zhang, Peng) [1] ; Bluestein, D (Bluestein, Danny) [1]

• Particle Method Simulation of Thrombus Formation in Fontan Route By:Tsubota, K (Tsubota, Ken-ichi) [1] ; Sughimoto, K (Sughimoto, Koichi) [2] ; Okauchi, K (Okauchi, Kazuki) [1] ; Liu, H (Liu, Hao) [1]

• Analysis of microvascular thrombus mechanobiology with a novel particle-based model By:Masalceva, AA (Masalceva, Anastasia A.) [1] , [2] ; Kaneva, VN (Kaneva, Valeriia N.) [1] , [2] , [3] ; Panteleev, MA (Panteleev, Mikhail A.) [1] , [2] , [3] , [4] ; Ataullakhanov, F (Ataullakhanov, Fazoil) [1] , [2] , [3] , [4] ; Volpert, V (Volpert, Vitaly) [5] , [6] , [7] ; Afanasyev, I (Afanasyev, Ilya) [8] , [9] ; Nechipurenko, DY (Nechipurenko, Dmitry Yu) [1] , [2] ,

• A Molecular Dynamics Based Multi-scale Platelet Aggregation Model and Its High-Throughput Simulation By:Xu, ZP (Xu, Zhipeng) [1] ; Zou, QS (Zou, Qingsong) [2]

• Particle hydrodynamic simulation of thrombus formation using velocity decay factor. Wang F, Xu S, Jiang D, Zhao B, Dong X, Zhou T, Luo X.

RESPONSE TO MAJOR COMMENTS:

We thank the reviewer for the recommendation to expand the literature review presented in the manuscript, and for suggesting several relevant papers. The references advised by the reviewer have been added in the revised manuscript:

“Zhang et al. [8] and Gao et al. [9] implemented a novel multiscale approach based on discrete particle methods to model thrombus formation in cardiovascular diseases by coupling the macroscopic flow conditions with cellular and molecular effects of platelet mechanical activation. Xu et al. [10] proposed a multi-scale approach where fluid was simulated on the macro-scale using dissipative particle dynamics, and the fine-scale receptors’ biochemical reactions were modelled by coarse-grained molecular dynamics.

Recently, a number of particle techniques had been developed to describe thrombosis. Tsubota et al. [30] presented a semi-implicit two-dimensional moving particle approach to model thrombus formation after Fontan surgery. In this model, fluid particles are converted into solid phase by adding internal spring forces when blood stasis condition occurs (the model does not consider biochemical factors). Masalceva et al. [31] developed a two-dimensional particle-based model including thrombus shell as aggregate of particles and thrombin specie. Also this approach neglects the biochemical reactions of the coagulation cascade and fibrin formation. Wang et al. [32] proposed a novel particle method to simulate thrombus formation employing a velocity decay factor linked to the fibrin concentration, to take into account the interaction with blood. Wang et al. [33] developed a dissipative particle dynamics model to study the adhesion and aggregation process of injured platelets on the collagen surface, by incorporating a model of high non-physiological shear stresses traumatised platelets to a viscoelastic model.

Ariane et al. [38] proposed a two-dimensional model to simulate the interaction between blood flow and emboli-like structures in a double venous valve system. In this approach no particle agglomeration is used to model emboli structures, that are considered as fixed. This technique was extended by Baksamawi et al. [39] including an algorithm based on geometrical distance for particle agglomeration.”

MINOR COMMENTS:

COMMENT 2.1:

Is there any convergence criterion for this simulation especially for the agglomeration algorithm? Or is it an open-loop computation?

RESPONSE 2.1:

No convergence criterion was needed for this simulation. However, we will consider the opportunity to include one for future developments of the model.

COMMENT 2.2:

What kind of particle does the author use at inlet section, periodic condition (if so, are the particle properties reset after the loop) or new particles.

RESPONSE 2.2:

New particles are introduced at the inlet section following the procedure described in Monteleone et al. [46]. This technique allows to handle open boundaries, guarantying a correct mass conservation through the balance of new particles which are continuously introduced in the computational domain through the inflow section and other particles which leave it through the outlet.

Following the reviewer’s suggestion, the following sentence has been included in the revised manuscript:

“In this study, the procedure described in Monteleone et al. [46] is used to handle open boundaries. This ensures mass conservation through the introduction of new particles in the computational domain, through the inflow section, balancing the particles which leave it through the outlet.”

COMMENT 2.3:

Section 3.3. references are needed to support the following sentence (‘the species do not affect the blood velocity in normal conditions’)

RESPONSE 2.3:

We apologise about the misleading phrasing of the statement ‘the species do not affect the blood velocity in normal conditions’, which is an assumption based on our understanding of the phenomenon, rather than on specific studies in the literature which we have not been able to source.

In the revised manuscript, we have clarified that this is an assumption in the model, with the sentence modified as follows:

“Moreover, it was assumed that the concentrations of the species do not affect the blood velocity in normal conditions, in the absence of thrombus.”

COMMENT 2.4:

Last phrase before section 4. Should be developed (‘the thrombus dissolution …….thrombus and embolise’)

RESPONSE 2.4:

We agree with the reviewer that the algorithm used to handle the thrombus dissolution should be discussed in detail. To this aim, one more figure has been added (Fig. 5 of the revised manuscript) and the manuscript has been modified as follows:

“In this study, potential thrombus dissolution is allowed through a procedure similar to that proposed by Tosenberger et al. [59] to model platelets adhesion. In particular, once the spring forms, it can be stretched up to a threshold distance lmax (corresponding to a limit local force), beyond which the link between the two particles is removed. Therefore, single particles or groups of particles bonded together can separate from the main thrombus and embolise. In Fig. 5 the length of the spring connecting the particles A and C become larger than lmax and thus the tie is removed. Since the spring connecting C and F is still active, and the clot including particles C and F is now detached from the main thrombus and can be carried by the flow and expand recruiting other particles from the fluid.”

Moreover, in section 4.1 (Thrombus formation in backward facing step) when discussing the validation test, the following sentences have been added in the revised manuscript:

“In this study, the threshold distance l_max considered for the springs dissolution (as discussed in section 3.3) was set equal to 1.1 k_h, as this value was found to lead to improved numerical stability and better correlation with experimental findings [41].”

COMMENT 2.5:

Figure 6: velocity vectors are too small, I suggest using a constant length instead and including colors for values gradient.

RESPONSE 2.5:

We appreciate the reviewer suggestion. We have tried to modify the figure using vectors with constant length coloured by velocity values. However, we feel that this does not improve the clarity and be misleading, requiring the use of two different scales for the velocity. Hence, we have preferred to maintain the current representation.

REFERENCES

[8] Zhang P, Zhang L, Slepian MJ, Deng Y, Bluestein D. A multiscale biomechanical model of platelets: Correlating with in-vitro results. J Biomech. 2017;50: 26–33. doi:10.1016/j.jbiomech.2016.11.019

[9] Gao C, Zhang P, Bluestein D. Multiscale Modeling of Mechanotransduction Processes in Flow-Induced Platelet Activation. 2016 IEEE 2nd International Conference on Big Data Security on Cloud (BigDataSecurity), IEEE International Conference on High Performance and Smart Computing (HPSC), and IEEE International Conference on Intelligent Data and Security (IDS). IEEE; 2016. pp. 274–279. doi:10.1109/BigDataSecurity-HPSC-IDS.2016.13

[10] Xu Z, Zou Q. A Molecular Dynamics Based Multi-scale Platelet Aggregation Model and Its High-Throughput Simulation. 2022. pp. 81–92. doi:10.1007/978-3-030-96772-7_8

[30] Tsubota K, Sughimoto K, Okauchi K, Liu H. Particle Method Simulation of Thrombus Formation in Fontan Route. 2016. pp. 387–396. doi:10.1007/978-3-319-40827-9_30

[31] Masalceva AA, Kaneva VN, Panteleev MA, Ataullakhanov F, Volpert V, Afanasyev I, et al. Analysis of microvascular thrombus mechanobiology with a novel particle-based model. J Biomech. 2022;130: 110801. doi:10.1016/j.jbiomech.2021.110801

[32] Wang F, Xu S, Jiang D, Zhao B, Dong X, Zhou T, et al. Particle hydrodynamic simulation of thrombus formation using velocity decay factor. Comput Methods Programs Biomed. 2021;207: 106173. doi:10.1016/j.cmpb.2021.106173

[33] Wang L, Chen Z, Zhang J, Zhang X, Wu ZJ. Modeling Clot Formation of Shear-Injured Platelets in Flow by a Dissipative Particle Dynamics Method. Bull Math Biol. 2020;82: 83. doi:10.1007/s11538-020-00760-9

[38] Ariane M, Vigolo D, Brill A, Nash FGB, Barigou M, Alexiadis A. Using Discrete Multi-Physics for studying the dynamics of emboli in flexible venous valves. Comput Fluids. 2018;166: 57–63. doi:10.1016/j.compfluid.2018.01.037

[39] Baksamawi HA, Ariane M, Brill A, Vigolo D, Alexiadis A. Modelling Particle Agglomeration on through Elastic Valves under Flow. ChemEngineering. 2021;5: 40. doi:10.3390/chemengineering5030040

[41] Taylor JO, Witmer KP, Neuberger T, Craven BA, Meyer RS, Deutsch S, et al. In Vitro Quantification of Time Dependent Thrombus Size Using Magnetic Resonance Imaging and Computational Simulations of Thrombus Surface Shear Stresses. J Biomech Eng. 2014;136. doi:10.1115/1.4027613

[46] Monteleone A, Monteforte M, Napoli E. Inflow/outflow pressure boundary conditions for smoothed particle hydrodynamics simulations of incompressible flows. Comput Fluids. 2017;159. doi:10.1016/j.compfluid.2017.09.011

[59] Tosenberger A, Ataullakhanov F, Bessonov N, Panteleev M, Tokarev A, Volpert V. Modelling of platelet–fibrin clot formation in flow with a DPD–PDE method. J Math Biol. 2016;72: 649–681. doi:10.1007/s00285-015-0891-2

Attachment

Submitted filename: Response to Reviewers.pdf

Decision Letter 1

Alessio Alexiadis

24 Jan 2023

Modelling of thrombus formation using smoothed particle hydrodynamics method

PONE-D-22-30268R1

Dear Dr. Burriesci,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Alessio Alexiadis

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have addressed my technical points and comments made previously.

The paper can be accepted for publication.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

Acceptance letter

Alessio Alexiadis

26 Jan 2023

PONE-D-22-30268R1

Modelling of thrombus formation using smoothed particle hydrodynamics method

Dear Dr. Burriesci:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Alessio Alexiadis

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to Reviewers.pdf

    Data Availability Statement

    All relevant data are within the paper.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES